Pharming Group N.V.

Yahoo Finance • 16 days ago

Pharming Group promoted to the Euronext AMX® index

Leiden, the Netherlands, September 10, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced that it has been promoted from the Euronext AScX® (Small Cap) to the AMX® (MidCap) index, effect... Full story

Yahoo Finance • 23 days ago

Pharming Group to present at the H.C. Wainwright 27th Annual Global Investment Conference

Leiden, the Netherlands, September 3, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming management will participate in the H.C. Wainwright 27th Annual Global Investment Conference in Ne... Full story

Yahoo Finance • 24 days ago

Pharming Group names new finance head

* Pharming Group (PHAR [https://seekingalpha.com/symbol/PHAR]) appointed [https://seekingalpha.com/pr/20216757-pharming-group-appoints-kenneth-lynard-as-chief-financial-officer] Kenneth Lynard as CFO, effective October 1, 2025. * Mr... Full story

Yahoo Finance • 24 days ago

Pharming Group appoints Kenneth Lynard as Chief Financial Officer

Leiden, the Netherlands, September 2, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced the appointment of Kenneth Lynard as Chief Financial Officer (CFO), effective October 1, 2025. M... Full story

Yahoo Finance • 2 months ago

Pharming Group to participate in August investor conference

Leiden, the Netherlands, August 4, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conference in the month of August: Canaccor... Full story

Yahoo Finance • 2 months ago

Pharming Group reports second quarter and first half 2025 financial results and provides business update

Second quarter 2025 total revenues increased by 26% to US$93.2 million, compared to the second quarter 2024, driven by strong RUCONEST® and Joenja® revenue growthRUCONEST® second quarter revenue increased by 28% to US$80.4 million, compare... Full story

Yahoo Finance • 3 months ago

KalVista Pharmaceuticals rises after FDA nod for Ekterly

[Blue Capsules on Conveyor at Modern Pharmaceutical Factory. Tablet and Capsule Manufacturing Process. Close-up Shot of Medical Drug Production Line.] SweetBunFactory/iStock via Getty Images * KalVista Pharmaceuticals (NASDAQ:KALV [http... Full story

Yahoo Finance • 3 months ago

US FDA approves KalVista Pharma's swelling disorder drug, shares rise

By Puyaan Singh (Reuters) -KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral treatment for a type of hereditary swelling disorder, sending its shares up more than... Full story

Yahoo Finance • 2 years ago

Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib

The multinational Phase III study is evaluating a new pediatric granulated formulation of leniolisib in children aged 1 to 6 years with APDS, a rare primary immunodeficiency Leiden, The Netherlands, November 21, 2023: Pharming Group N.V.... Full story

Yahoo Finance • 2 years ago

Sequana Medical announces results of Special General Meeting of Shareholders

PRESS RELEASE REGULATED INFORMATION 26 June 2023,06:00 pm CEST Dr. Kenneth Macleod appointed as non-executive director Ghent, Belgium – 26 June 2023– Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "SequanaMedical"), a... Full story

Yahoo Finance • 2 years ago

Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023

LEIDEN, Netherlands, April 26, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces that Pharming's Chief Executive Officer, Sijmen de Vries will attend the H.C. Wainwright BioConnect I... Full story

Yahoo Finance • 2 years ago

Pharming Group convenes the Annual General Meeting of Shareholders 2023

LEIDEN, Netherlands, April 5, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (Nasdaq: PHAR) announces that the Company's 2023 Annual General Meeting of Shareholders (AGM) will be held on Wednesday,... Full story

Yahoo Finance • 3 years ago

Dutch biotech Pharming says it held $45 mln in collapsed SVB

AMSTERDAM, March 12 (Reuters) - Dutch biotech firm Pharming said on Sunday it held $45 million in collapsed U.S. lender Silicon Valley Bank's British and U.S. units and that it will seek to recover the funds. Pharming said it held $26 mil... Full story

Yahoo Finance • 3 years ago

Pharming Group Notice of Q3 Results

LEIDEN, Netherlands, Oct. 12, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) confirms it will announce financial results for the nine months ended September 30, 2022 on Thu... Full story

Yahoo Finance • 3 years ago

Pharming submits a Marketing Authorisation Application to the European Medicines Agency for Leniolisib

Application is based on randomized, controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency This submission follows the grant of accelerated assessment allowing an expedited review f... Full story

Yahoo Finance • 4 years ago

Pharming Announces Presentation of Positive Results of Phase III Leniolisib Trial in APDS at Clinical Immunology Society 2022 Annual Meeting

Principal Investigator Dr. V. Koneti Rao Will Share Data Supporting the Investigational Treatment for Activated PI3K Delta Syndrome (APDS) LEIDEN, Netherlands, March 28, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company... Full story